Lunai Bioworks LNAI
NASDAQ LNAI
$0.52 +0.05 (+10.13%)
As of: Oct 20, 2026 · 12:53 PM EDT

Lunai Bioworks (LNAI) FCF Margin (2013 - 2026)

Updated

Lunai Bioworks (LNAI) reported FCF Margin of -4903.33% for fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Lunai Bioworks (LNAI) FCF Margin (2013 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Lunai Bioworks' FCF Margin came in at -6169.78%; for FY2016 (ended Jun 30, 2016), it was -3442.42%.

  • FCF Margin has a four-year change of -1956.87 percentage points (FY2012 to FY2016).
  • By fiscal year, FCF Margin came in at -2546.43% in FY2015, -6502.16% in FY2013 (-5016.61 pp) and -1485.55% in FY2012.
  • The fiscal Q3 2026 figure ranks as the highest quarterly FCF Margin since fiscal Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,152.93 Bn 1,121.51 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 623.85 Bn 542.38 Bn 17.26 Bn 28.82%
3 AbbVie 512.32 Bn 485.43 Bn 12.70 Bn 18.33%
4 Merck 365.51 Bn 319.89 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.25 Bn 261.24 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.29 Bn 234.98 Bn 12.86 Bn 6.55%
7 Amgen 234.60 Bn 190.00 Bn 7.24 Bn 34.70%
8 Gilead Sciences 192.87 Bn 167.07 Bn 6.22 Bn 44.00%
9 Pfizer 171.71 Bn 118.36 Bn 10.94 Bn 2.01%
10 Lunai Bioworks 1.62 Mn -3.13 Mn 20,942.00 -4,903.33%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4,903.33%
Dec 31, 2023 -19,742.90%
Sep 30, 2023 -33,160.68%
Jun 30, 2023 -30,988.70%
Dec 31, 2022 -117,989.07%
Sep 30, 2022 -47,193.21%
Jun 30, 2022 -3,076.82%
Mar 31, 2022 -38,193.64%
Mar 31, 2013 -3,561.38%
API Access

Lunai Bioworks FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=LNAI&period=max&api_key=YOUR_API_KEY